259 related articles for article (PubMed ID: 37046628)
1. Precision Oncology: Evolving Clinical Trials across Tumor Types.
Song IW; Vo HH; Chen YS; Baysal MA; Kahle M; Johnson A; Tsimberidou AM
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046628
[TBL] [Abstract][Full Text] [Related]
2. The New NCI Precision Medicine Trials.
Harris LN; Blanke CD; Erba HP; Ford JM; Gray RJ; LeBlanc ML; Hu-Lieskovan S; Litzow MR; Luger SM; Meric-Bernstam F; O'Dwyer PJ; Othus MKD; Politi K; Shepherd LE; Allegra CJ; Chen HX; Ivy SP; Korde LA; Little RF; McShane LM; Moscow JA; Patton DR; Thurin M; Yee LM; Doroshow JH
Clin Cancer Res; 2023 Dec; 29(23):4728-4732. PubMed ID: 37531248
[TBL] [Abstract][Full Text] [Related]
3. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
Do K; O'Sullivan Coyne G; Chen AP
Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
[TBL] [Abstract][Full Text] [Related]
4. National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH).
Meric-Bernstam F; Ford JM; O'Dwyer PJ; Shapiro GI; McShane LM; Freidlin B; O'Cearbhaill RE; George S; Glade-Bender J; Lyman GH; Tricoli JV; Patton D; Hamilton SR; Gray RJ; Hawkins DS; Ramineni B; Flaherty KT; Grivas P; Yap TA; Berlin J; Doroshow JH; Harris LN; Moscow JA
Clin Cancer Res; 2023 Apr; 29(8):1412-1422. PubMed ID: 36662819
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial design in the era of precision medicine.
Fountzilas E; Tsimberidou AM; Vo HH; Kurzrock R
Genome Med; 2022 Aug; 14(1):101. PubMed ID: 36045401
[TBL] [Abstract][Full Text] [Related]
6. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
Schmidt KT; Chau CH; Price DK; Figg WD
J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
[TBL] [Abstract][Full Text] [Related]
7. Molecular tumour boards - current and future considerations for precision oncology.
Tsimberidou AM; Kahle M; Vo HH; Baysal MA; Johnson A; Meric-Bernstam F
Nat Rev Clin Oncol; 2023 Dec; 20(12):843-863. PubMed ID: 37845306
[TBL] [Abstract][Full Text] [Related]
8. Overview of precision oncology trials: challenges and opportunities.
Fountzilas E; Tsimberidou AM
Expert Rev Clin Pharmacol; 2018 Aug; 11(8):797-804. PubMed ID: 30044653
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.
Vo HH; Fu S; Hong DS; Karp DD; Piha-Paul S; Subbiah V; Janku F; Naing A; Yap TA; Rodon J; Ajani JA; Cartwright C; Johnson A; Song IW; Beck J; Kahle M; Nogueras-Gonzalez GM; Miller V; Chao C; Vining DJ; Berry DA; Meric-Bernstam F; Tsimberidou AM
NPJ Precis Oncol; 2022 Oct; 6(1):78. PubMed ID: 36302890
[TBL] [Abstract][Full Text] [Related]
10. ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
Kringelbach T; Højgaard M; Rohrberg K; Spanggaard I; Laursen BE; Ladekarl M; Haslund CA; Harsløf L; Belcaid L; Gehl J; Søndergaard L; Eefsen RL; Hansen KH; Kodahl AR; Jensen LH; Holt MI; Oellegaard TH; Yde CW; Ahlborn LB; Lassen U
BMC Cancer; 2023 Feb; 23(1):182. PubMed ID: 36814246
[TBL] [Abstract][Full Text] [Related]
11. Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
Heymach J; Krilov L; Alberg A; Baxter N; Chang SM; Corcoran RB; Dale W; DeMichele A; Magid Diefenbach CS; Dreicer R; Epstein AS; Gillison ML; Graham DL; Jones J; Ko AH; Lopez AM; Maki RG; Rodriguez-Galindo C; Schilsky RL; Sznol M; Westin SN; Burstein H
J Clin Oncol; 2018 Apr; 36(10):1020-1044. PubMed ID: 29380678
[TBL] [Abstract][Full Text] [Related]
12. The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP).
Haj Mohammad SF; Timmer HJL; Zeverijn LJ; Geurts BS; Spiekman IAC; Verkerk K; Verbeek FAJ; Verheul HMW; Voest EE; Gelderblom H
Acta Oncol; 2024 May; 63():368-372. PubMed ID: 38779868
[TBL] [Abstract][Full Text] [Related]
13. Precision oncology: a clinical and patient perspective.
Lassen UN; Makaroff LE; Stenzinger A; Italiano A; Vassal G; Garcia-Foncillas J; Avouac B
Future Oncol; 2021 Oct; 17(30):3995-4009. PubMed ID: 34278817
[TBL] [Abstract][Full Text] [Related]
14. Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers.
Karim F; Amin A; Liu M; Vishnuvardhan N; Amin S; Shabbir R; Swed B; Khan U
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627127
[TBL] [Abstract][Full Text] [Related]
15. GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical Trials.
Zhao Y; Polley EC; Li MC; Lih CJ; Palmisano A; Sims DJ; Rubinstein LV; Conley BA; Chen AP; Williams PM; Kummar S; Doroshow JH; Simon RM
Cancer Inform; 2015; 14(Suppl 2):45-55. PubMed ID: 25861217
[TBL] [Abstract][Full Text] [Related]
16. Is the NCI MATCH trial a match for gynecologic oncology?
Moore KN; Mannel RS
Gynecol Oncol; 2016 Jan; 140(1):161-6. PubMed ID: 26586415
[TBL] [Abstract][Full Text] [Related]
17. Current Challenges in Cancer Treatment.
Zugazagoitia J; Guedes C; Ponce S; Ferrer I; Molina-Pinelo S; Paz-Ares L
Clin Ther; 2016 Jul; 38(7):1551-66. PubMed ID: 27158009
[TBL] [Abstract][Full Text] [Related]
18. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
19. Challenges, opportunities, and innovative statistical designs for precision oncology trials.
Yin J; Shen S; Shi Q
Ann Transl Med; 2022 Sep; 10(18):1038. PubMed ID: 36267789
[TBL] [Abstract][Full Text] [Related]
20. Complexity of Delivering Precision Medicine: Opportunities and Challenges.
Davis AA; McKee AE; Kibbe WA; Villaflor VM
Am Soc Clin Oncol Educ Book; 2018 May; 38():998-1007. PubMed ID: 30231318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
